interval between 0.61 and 1.21 mg/L was defined [4] . Newman et al. [5] used 1.25 mg/L as the upper reference value. However, all these references values were established in a very limited number of subjects (n ϭ 27) [4] . Using an ELISA method, we previously found higher values [3] . These differences are very likely explained by The slope for serum creatinine was significantly different from zero (P Ͻ0.0001). By contrast, Cys-C vs age and ␤2-MG vs age showed slopes not significantly different from zero.
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Clinical Chemistry 43, No. 6, 1997 the different calibrator material used in the different studies. In the present study, the same calibrator material (recombinant Cys-C) was used as in the studies of Kyhse-Anderson et al. [4] and Newman et al. [5] , whereas we calibrated the ELISA method with a urinary protein calibrator of Cys-C (Behring, Marburg, Germany). To date, there are no published Cys-C reference limits for children. Our ␤2-MG reference values match well with the published reference values [9] for healthy children (95th percentile 2.20 mg/L).
Measurement of serum creatinine can be performed by various methods. The results can be influenced by numerous factors, and each method will produce different normal values for adults and children [10] . In addition to GFR, muscle mass and physical activity also influence the creatinine concentration [10] , and thus impairment of GFR may easily be overlooked in young children. Here, Cys-C or ␤2-MG may serve as a useful alternative. Our data clearly demonstrate age independency for serum concentrations of both Cys-C and ␤2-MG. Cys-C concentrations Ͼ1.4 mg/L and ␤2-MG concentrations Ͼ2.3 mg/L suggest an impaired GFR irrespective of age; hence, measurement of Cys-C or ␤2-MG concentrations may be advantageous compared with measurements of serum creatinine concentration for the detection of an impaired GFR.
Interference of Methylene Blue with CO-Oximetry of
Hemoglobin Derivatives, Hervé Gourlain, 1 * Françoise Buneaux, 1 Stephen W. Borron, 2 Bernard Gouget, 3 Methylene blue (MB) is frequently used as an antidote in treating methemoglobinemia [1] because it facilitates the reducing activity of the NADPH-dependent methemoglobin reductase system in erythrocytes [2] . However, MB absorbs strongly between 550 and 700 nm (Fig. 1) , the same spectrophotometric region as that of the various hemoglobin derivatives: oxyhemoglobin (O 2 Hb), deoxyhemoglobin (HHb), methemoglobin (MetHb), and carboxyhemoglobin (COHb). To evaluate the potential magnitude and direction of errors linked to the presence of MB for the results for total hemoglobin (tHb) and its derivatives, we evaluated six CO-Oximeters. The wavelengths used by each instrument for these determinations are as follows: IL 482 (Instrumentation Laboratory, Lexington, MA), 535, 585.2, 594.5, and 626.6 nm; CCD 270 (Chiron Diagnostics, Medfield, MA), 557, 577, 597, 605, 624, 635, and 650 nm; CCD 835 (Chiron; wavelengths not communicated); OSM3 (Radiometer, Copenhagen, Denmark), 535, 560, 577, 622, 636, and 670 nm; ABL 520 (Radiometer; same wavelengths as OSM3); AVL 912 (AVL Scientific Corp., Roswell, GA), 530, 536, 542, 548, 554, 560, 566, 572, 578, 584, 590, 604, 612, 622, 630, 640, and 648 nm.
Blood was collected from five healthy volunteers with informed consent. Because the study involved only blood sampling, Institutional Ethics Committee Review was not required in France. The five samples were combined to obtain 120 mL of pooled blood, which were then separated into three 40-mL fractions:
-Fraction N, which had no enrichment in CO or MetHb.
-Fraction CO, which was enriched in CO by tonometry with use of an IL 237 tonometer (Instrumentation Laboratory) and CO in nitrogen, 10 mL/L (Société Cosma, Igny 91430, France). Because of the time required to analyze a large number of samples, the tonometry was carried out separately on four 10-mL specimens just before analysis.
-Fraction Met, which was treated with 4 mg of hydroquinone (Prolabo, Paris, France) to obtain samples enriched in MetHb. Hydroquinone, a known inducer of MetHb, was selected for its lack of absorbance in the spectral range of hemoglobin. Again, this enrichment step was carried out on four 10-mL specimens just before analysis.
Each fraction was separated into aliquots. Four aliquots were adulterated with MB by dilution with a stock 10 g/L solution (Pharmacie Centrale des Hô pitaux de Paris, Paris, France) to obtain final concentrations of 0.1, 0.25, 0.50, and 1 g/L. We then added 1.0 mL of one of these solutions to 9.0 mL of blood to obtain a blood MB concentration of 10, 25, 50, or 100 mg/L. These MB concentrations were chosen to correspond to the plasma concentrations clinically anticipated when MB is slowly injected intravenously as 5-25 mL of a 10 g/L solution (the 100 mg/L concentration is rarely attained). Four control aliquots were prepared for each fraction as well, the MB being replaced with NaCl, 9 g/L. Each adulterated sample was compared with its own control, and measurement was performed immediately after treatment of the blood with either MB or NaCl. Measurements were performed in triplicate with all six CO-Oximeters.
The tHb concentrations of controls measured by CO-Oximetry were ϳ146 g/L. The COHb and MetHb percent-1078 Technical Briefs
